These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 9184925)

  • 1. Cytotoxic T lymphocytes derived from bone marrow mononuclear cells of multiple myeloma patients recognize an underglycosylated form of MUC1 mucin.
    Noto H; Takahashi T; Makiguchi Y; Hayashi T; Hinoda Y; Imai K
    Int Immunol; 1997 May; 9(5):791-8. PubMed ID: 9184925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of MUC1 on myeloma cells and induction of HLA-unrestricted CTL against MUC1 from a multiple myeloma patient.
    Takahashi T; Makiguchi Y; Hinoda Y; Kakiuchi H; Nakagawa N; Imai K; Yachi A
    J Immunol; 1994 Sep; 153(5):2102-9. PubMed ID: 8051415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytotoxic T lymphocytes from humans with adenocarcinomas stimulated by native MUC1 mucin and a mucin peptide mutated at a glycosylation site.
    Wright SE; Kilinski L; Talib S; Lowe KE; Burnside JS; Wu JY; Dolby N; Dombrowski KE; Lebkowski JS; Philip R
    J Immunother; 2000 Jan; 23(1):2-10. PubMed ID: 10687132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. O-glycosylated versus non-glycosylated MUC1-derived peptides as potential targets for cytotoxic immunotherapy of carcinoma.
    Stepensky D; Tzehoval E; Vadai E; Eisenbach L
    Clin Exp Immunol; 2006 Jan; 143(1):139-49. PubMed ID: 16367945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced induction of anti-tumor CTLs in vitro by a lentivirus-transduced dendritic cell vaccine expressing secondary lymphoid tissue chemokine and mucin 1.
    Wang B; Zhu Y; Zhang JJ; Chen Z; Liang WB; Xu ZK
    Asian Pac J Cancer Prev; 2011; 12(11):2811-7. PubMed ID: 22393946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of myeloma-specific cytotoxic T cells using dendritic cells transfected with tumor-derived RNA.
    Milazzo C; Reichardt VL; Müller MR; Grünebach F; Brossart P
    Blood; 2003 Feb; 101(3):977-82. PubMed ID: 12393470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of HLA-A2-restricted T-cell epitopes derived from the MUC1 tumor antigen for broadly applicable vaccine therapies.
    Brossart P; Heinrich KS; Stuhler G; Behnke L; Reichardt VL; Stevanovic S; Muhm A; Rammensee HG; Kanz L; Brugger W
    Blood; 1999 Jun; 93(12):4309-17. PubMed ID: 10361129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential expression of MUC1 on transfected cell lines influences its recognition by MUC1 specific T cells.
    Magarian-Blander J; Hughey RP; Kinlough C; Poland PA; Finn OJ
    Glycoconj J; 1996 Oct; 13(5):749-56. PubMed ID: 8910002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening of anti-MUC1 antibodies for reactivity with native (ascites) and recombinant (baculovirus) MUC1 and for blocking MUC1 specific cytotoxic T-lymphocytes.
    Ciborowski P; Konitzki WM; Blander JM; Finn OJ
    Tumour Biol; 1998; 19 Suppl 1():147-51. PubMed ID: 9422100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recognition of pleural mesothelioma by mucin-1(950-958)/human leukocyte antigen A*0201-specific CD8+ T-cells.
    Roulois D; Vignard V; Gueugnon F; Labarrière N; Grégoire M; Fonteneau JF
    Eur Respir J; 2011 Nov; 38(5):1117-26. PubMed ID: 21540305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retention of immunogenicity produced by mucin 1 peptides with glycosylation site substitutions.
    Wright SE; Quinlin IS; Rewers-Felkins KA; Dombrowski KE; Phillips CA
    Immunopharmacol Immunotoxicol; 2010 Dec; 32(4):647-55. PubMed ID: 20470225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adoptive immunotherapy for pancreatic cancer: cytotoxic T lymphocytes stimulated by the MUC1-expressing human pancreatic cancer cell line YPK-1.
    Kawaoka T; Oka M; Takashima M; Ueno T; Yamamoto K; Yahara N; Yoshino S; Hazama S
    Oncol Rep; 2008 Jul; 20(1):155-63. PubMed ID: 18575732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The epithelial tumor antigen MUC1 is expressed in hematological malignancies and is recognized by MUC1-specific cytotoxic T-lymphocytes.
    Brossart P; Schneider A; Dill P; Schammann T; Grünebach F; Wirths S; Kanz L; Bühring HJ; Brugger W
    Cancer Res; 2001 Sep; 61(18):6846-50. PubMed ID: 11559560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transfection of dendritic cells with RNA induces CD4- and CD8-mediated T cell immunity against breast carcinomas and reveals the immunodominance of presented T cell epitopes.
    Müller MR; Grünebach F; Nencioni A; Brossart P
    J Immunol; 2003 Jun; 170(12):5892-6. PubMed ID: 12794115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CTL in mice immunized with human mucin 1 are MHC-restricted.
    Apostolopoulos V; Loveland BE; Pietersz GA; McKenzie IF
    J Immunol; 1995 Dec; 155(11):5089-94. PubMed ID: 7594517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mucin-1-related T cell infiltration in colorectal carcinoma.
    Mulder WM; Stukart MJ; de Windt E; Wagstaff J; Scheper RJ; Bloemena E
    Cancer Immunol Immunother; 1996 Jul; 42(6):351-6. PubMed ID: 8830738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intercellular and intracellular events following the MHC-unrestricted TCR recognition of a tumor-specific peptide epitope on the epithelial antigen MUC1.
    Magarian-Blander J; Ciborowski P; Hsia S; Watkins SC; Finn OJ
    J Immunol; 1998 Apr; 160(7):3111-20. PubMed ID: 9531265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel breast-tumor-associated MUC1-derived peptides: characterization in Db-/- x beta2 microglobulin (beta2m) null mice transgenic for a chimeric HLA-A2.1/Db-beta2 microglobulin single chain.
    Carmon L; El-Shami KM; Paz A; Pascolo S; Tzehoval E; Tirosh B; Koren R; Feldman M; Fridkin M; Lemonnier FA; Eisenbach L
    Int J Cancer; 2000 Feb; 85(3):391-7. PubMed ID: 10652432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An autologous therapeutic dendritic cell vaccine transfected with total lung carcinoma RNA stimulates cytotoxic T lymphocyte responses against non-small cell lung cancer.
    Wang K; Zhou Q; Guo AL; Xu CR; An SJ; Wu YL
    Immunol Invest; 2009; 38(7):665-80. PubMed ID: 19811429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MHC-unrestricted lysis of MUC1-expressing cells by human peripheral blood mononuclear cells.
    Wright SE; Rewers-Felkins KA; Quinlin IS; Fogler WE; Phillips CA; Townsend M; Robinson W; Philip R
    Immunol Invest; 2008; 37(3):215-25. PubMed ID: 18389441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.